The trademark application SKY-SEQ was filed by Skyhawk Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 6, 2021, and it was registered by office on September 13, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and address of the trademark registration was recorded on January 8, 2024. Change of name and address of the trademark registration was recorded on February 22, 2024.
Goods And Services
The mark was filed in class 42 with Provision of integrated and high-throughput screening technologies coupled with next generation sequencing for research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases and development of integrated and high-throughput screening technologies coupled with next-generation sequencing for research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases..